
BrainCheck secured $13M in Series A funding to scale its enterprise cognitive care infrastructure, w...
The AMW Read
This is an incremental update to the Healthcare/Bio player map via a Series A funding round for a specialized cognitive care platform.
BrainCheck secured $13M in Series A funding to scale its enterprise cognitive care infrastructure, with 640,000+ assessments completed across 500+ healthcare organizations. This funding signals a critical shift from fragmented cognitive testing to systematic, AI-assisted longitudinal care programs designed for value-based healthcare models. The strategic backing from UPMC Enterprises validates the clinical utility and positions digital cognitive assessment as essential infrastructure for population health management. As healthcare economics increasingly reward patient outcomes over service volume, platforms like BrainCheck are transforming cognitive health from reactive diagnosis to proactive, ongoing monitoring.



